Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2021

Open Access 01-12-2021 | Pneumonia | Research

Comparison of clinical features and prognosis in patients with cryptogenic and secondary organizing pneumonia

Authors: Keum-Ju Choi, Eun-Hyung Yoo, Kyung Chan Kim, Eun Jin Kim

Published in: BMC Pulmonary Medicine | Issue 1/2021

Login to get access

Abstract

Background

Organizing pneumonia (OP) can be diagnosed pathologically, and cryptogenic OP (COP) and secondary OP (SOP) have been classified by cause and particular underlying context. Because it is clinically difficult to differentiate between COP and SOP, this study investigated characteristics that could distinguish between COP and SOP.

Methods

The medical records of patients who underwent lung biopsy for a diagnosis of OP at a single tertiary hospital from January 2016 to December 2018 were retrospectively reviewed.

Results

Eighty-five patients had pathologically proven OP, including 16 diagnosed with COP and 69 diagnosed with SOP. The most common cause of SOP was infectious pneumonia, observed in 57 (82.6%) of the 69 patients, followed by cancer and radiation pneumonitis. The pathogens causing infectious pneumonia were identified in 45 (65.2%) patients. There were no differences in age, sex, and lung function between the COP and SOP groups. Median body mass index was significantly lower (P = 0.030), and median time from symptom onset to hospital admission significantly shorter (P = 0.006), in the SOP than in the COP group. Fever was more common in the SOP group (P = 0.024), and CURB 65, an index of pneumonia severity, tended to be higher in the SOP group (P = 0.017). Some laboratory results differed significantly between the two groups. Lymphocyte counts in bronchoalveolar lavage (BAL) fluid were significantly higher in the COP than in the SOP group (P = 0.012). Radiologic findings showed that effusion was more common in the SOP group (P = 0.036). There were no between-group differences in steroid use, 30 day and in-hospital mortality rates, and rates of OP outcomes and recurrences. Pneumonia recurrence rate was significantly higher in SOP patients who were than were not treated with steroids (P = 0.035).

Conclusions

Infection is the main cause of SOP. Symptom onset is more rapid in patients with SOP than with COP. Some blood and BAL fluid test results differed significantly in the COP and SOP groups. Pleural effusion was more common in the SOP group but there were no differences in clinical course. Recurrence in patients with SOP was more common in those who were than were not treated with steroids.
Literature
1.
go back to reference Epler GR, Colby TV, McLoud TC, Carrington CB, Gaensler EA. Bronchiolitis obliterans organizing pneumonia. N Engl J Med. 1985;312(3):152–8.CrossRef Epler GR, Colby TV, McLoud TC, Carrington CB, Gaensler EA. Bronchiolitis obliterans organizing pneumonia. N Engl J Med. 1985;312(3):152–8.CrossRef
2.
go back to reference Epler GR. Bronchiolitis obliterans organizing pneumonia, 25 years: a variety of causes, but what are the treatment options? Expert Rev Respir Med. 2011;5(3):353–61.CrossRef Epler GR. Bronchiolitis obliterans organizing pneumonia, 25 years: a variety of causes, but what are the treatment options? Expert Rev Respir Med. 2011;5(3):353–61.CrossRef
3.
go back to reference Tripier R. Traité d’anatomie pathologique générale. Masson; 1904. Tripier R. Traité d’anatomie pathologique générale. Masson; 1904.
4.
go back to reference Davison A, Heard B, McAllister W. Steroid-responsive relapsing cryptogenic organizing pneumonitis. Br Med J Publ Group Br Med Assoc House. 1982;25:785–6. Davison A, Heard B, McAllister W. Steroid-responsive relapsing cryptogenic organizing pneumonitis. Br Med J Publ Group Br Med Assoc House. 1982;25:785–6.
5.
go back to reference American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002;165(2):277–304.CrossRef American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002;165(2):277–304.CrossRef
6.
go back to reference Baque-Juston M, Pellegrin A, Leroy S, Marquette CH, Padovani B. Organizing pneumonia: what is it? A conceptual approach and pictorial review. Diagn Interv Imaging. 2014;95(9):771–7.CrossRef Baque-Juston M, Pellegrin A, Leroy S, Marquette CH, Padovani B. Organizing pneumonia: what is it? A conceptual approach and pictorial review. Diagn Interv Imaging. 2014;95(9):771–7.CrossRef
7.
go back to reference Roberton BJ, Hansell DM. Organizing pneumonia: a kaleidoscope of concepts and morphologies. Eur Radiol. 2011;21(11):2244–54.CrossRef Roberton BJ, Hansell DM. Organizing pneumonia: a kaleidoscope of concepts and morphologies. Eur Radiol. 2011;21(11):2244–54.CrossRef
8.
9.
go back to reference Flaherty KR, King TE, Raghu G, Lynch JP, Colby TV, Travis WD, Gross BH, Kazerooni EA, Toews GB, Long Q, et al. Idiopathic interstitial pneumonia. Am J Respir Crit Care Med. 2004;170(8):904–10.CrossRef Flaherty KR, King TE, Raghu G, Lynch JP, Colby TV, Travis WD, Gross BH, Kazerooni EA, Toews GB, Long Q, et al. Idiopathic interstitial pneumonia. Am J Respir Crit Care Med. 2004;170(8):904–10.CrossRef
10.
go back to reference Baha A, Yıldırım F, Köktürk N, Galata Z, Akyürek N, Demirci NY, Türktaş H. Cryptogenic and secondary organizing pneumonia: clinical presentation, radiological and laboratory findings, treatment, and prognosis in 56 cases. Turk Thorac J. 2018;19(4):201.CrossRef Baha A, Yıldırım F, Köktürk N, Galata Z, Akyürek N, Demirci NY, Türktaş H. Cryptogenic and secondary organizing pneumonia: clinical presentation, radiological and laboratory findings, treatment, and prognosis in 56 cases. Turk Thorac J. 2018;19(4):201.CrossRef
11.
go back to reference Basarakodu KR, Aronow WS, Nair CK, Lakkireddy D, Kondur A, Korlakunta H, Valasareddi SL, Lem V, Schuller D. Differences in treatment and in outcomes between idiopathic and secondary forms of organizing pneumonia. Am J Ther. 2007;14(5):422–6.CrossRef Basarakodu KR, Aronow WS, Nair CK, Lakkireddy D, Kondur A, Korlakunta H, Valasareddi SL, Lem V, Schuller D. Differences in treatment and in outcomes between idiopathic and secondary forms of organizing pneumonia. Am J Ther. 2007;14(5):422–6.CrossRef
12.
go back to reference Drakopanagiotakis F, Paschalaki K, Abu-Hijleh M, Aswad B, Karagianidis N, Kastanakis E, Braman SS, Polychronopoulos V. Cryptogenic and secondary organizing pneumonia: clinical presentation, radiographic findings, treatment response, and prognosis. Chest. 2011;139(4):893–900.CrossRef Drakopanagiotakis F, Paschalaki K, Abu-Hijleh M, Aswad B, Karagianidis N, Kastanakis E, Braman SS, Polychronopoulos V. Cryptogenic and secondary organizing pneumonia: clinical presentation, radiographic findings, treatment response, and prognosis. Chest. 2011;139(4):893–900.CrossRef
13.
go back to reference Lohr RH, Boland BJ, Douglas WW, Dockrell DH, Colby TV, Swensen SJ, Wollan PC, Silverstein MD. Organizing pneumonia: features and prognosis of cryptogenic, secondary, and focal variants. Arch Intern Med. 1997;157(12):1323–9.CrossRef Lohr RH, Boland BJ, Douglas WW, Dockrell DH, Colby TV, Swensen SJ, Wollan PC, Silverstein MD. Organizing pneumonia: features and prognosis of cryptogenic, secondary, and focal variants. Arch Intern Med. 1997;157(12):1323–9.CrossRef
14.
go back to reference Vasu TS, Cavallazzi R, Hirani A, Sharma D, Weibel SB, Kane GC. Clinical and radiologic distinctions between secondary bronchiolitis obliterans organizing pneumonia and cryptogenic organizing pneumonia. Respir Care. 2009;54(8):1028–32.PubMed Vasu TS, Cavallazzi R, Hirani A, Sharma D, Weibel SB, Kane GC. Clinical and radiologic distinctions between secondary bronchiolitis obliterans organizing pneumonia and cryptogenic organizing pneumonia. Respir Care. 2009;54(8):1028–32.PubMed
15.
go back to reference Chang J, Han J, Kim DW, Lee I, Lee KY, Jung S, Han HS, Chun BK, Cho SJ, Lee K, et al. Bronchiolitis obliterans organizing pneumonia: clinicopathologic review of a series of 45 Korean patients including rapidly progressive form. J Korean Med Sci. 2002;17(2):179–86.CrossRef Chang J, Han J, Kim DW, Lee I, Lee KY, Jung S, Han HS, Chun BK, Cho SJ, Lee K, et al. Bronchiolitis obliterans organizing pneumonia: clinicopathologic review of a series of 45 Korean patients including rapidly progressive form. J Korean Med Sci. 2002;17(2):179–86.CrossRef
16.
17.
go back to reference Mehrjardi MZ, Kahkouee S, Pourabdollah M. Radio-pathological correlation of organizing pneumonia (OP): a pictorial review. Br J Radiol. 2017;90(1071):20160723.CrossRef Mehrjardi MZ, Kahkouee S, Pourabdollah M. Radio-pathological correlation of organizing pneumonia (OP): a pictorial review. Br J Radiol. 2017;90(1071):20160723.CrossRef
18.
go back to reference Tiralongo F, Palermo M, Distefano G, Vancheri A, Sambataro G, Torrisi SE, Galioto F, Ferlito A, Fazio G, Foti PV, et al. Cryptogenic organizing pneumonia: evolution of morphological patterns assessed by HRCT. Diagnostics. 2020;10(5):262.CrossRef Tiralongo F, Palermo M, Distefano G, Vancheri A, Sambataro G, Torrisi SE, Galioto F, Ferlito A, Fazio G, Foti PV, et al. Cryptogenic organizing pneumonia: evolution of morphological patterns assessed by HRCT. Diagnostics. 2020;10(5):262.CrossRef
19.
go back to reference Maldonado F, Daniels CE, Hoffman EA, Yi ES, Ryu JH. Focal organizing pneumonia on surgical lung biopsy: causes, clinicoradiologic features, and outcomes. Chest. 2007;132(5):1579–83.CrossRef Maldonado F, Daniels CE, Hoffman EA, Yi ES, Ryu JH. Focal organizing pneumonia on surgical lung biopsy: causes, clinicoradiologic features, and outcomes. Chest. 2007;132(5):1579–83.CrossRef
20.
go back to reference Melloni G, Cremona G, Bandiera A, Arrigoni G, Rizzo N, Varagona R, Muriana G, Carretta A, Ciriaco P, Canneto B, et al. Localized organizing pneumonia: report of 21 cases. Ann Thorac Surg. 2007;83(6):1946–51.CrossRef Melloni G, Cremona G, Bandiera A, Arrigoni G, Rizzo N, Varagona R, Muriana G, Carretta A, Ciriaco P, Canneto B, et al. Localized organizing pneumonia: report of 21 cases. Ann Thorac Surg. 2007;83(6):1946–51.CrossRef
21.
go back to reference Huo Z, Feng R, Tian X, Zhang H, Huo L, Liu H. Clinicopathological findings of focal organizing pneumonia: a retrospective study of 37 cases. Int J Clin Exp Pathol. 2015;8(1):511–6.PubMedPubMedCentral Huo Z, Feng R, Tian X, Zhang H, Huo L, Liu H. Clinicopathological findings of focal organizing pneumonia: a retrospective study of 37 cases. Int J Clin Exp Pathol. 2015;8(1):511–6.PubMedPubMedCentral
22.
go back to reference Murray PR, Washington JA. Microscopic and baceriologic analysis of expectorated sputum. Mayo Clin Proc. 1975;50(6):339–44.PubMed Murray PR, Washington JA. Microscopic and baceriologic analysis of expectorated sputum. Mayo Clin Proc. 1975;50(6):339–44.PubMed
23.
go back to reference Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CPM, Gustafsson P, Hankinson J, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948–68.CrossRef Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CPM, Gustafsson P, Hankinson J, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948–68.CrossRef
24.
go back to reference Lazor R, Vandevenne A, Pelletier A, Leclerc P, Court-Fortune I, Cordier JF. Cryptogenic organizing pneumonia. Characteristics of relapses in a series of 48 patients. The Groupe d’Etudes et de Recherche sur les Maladles “Orphelines” Pulmonaires (GERM"O"P). Am J Respir Crit Care Med. 2000;162(2 Pt 1):571–7.CrossRef Lazor R, Vandevenne A, Pelletier A, Leclerc P, Court-Fortune I, Cordier JF. Cryptogenic organizing pneumonia. Characteristics of relapses in a series of 48 patients. The Groupe d’Etudes et de Recherche sur les Maladles “Orphelines” Pulmonaires (GERM"O"P). Am J Respir Crit Care Med. 2000;162(2 Pt 1):571–7.CrossRef
25.
go back to reference Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, Lewis SA, Macfarlane JT. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377–82.CrossRef Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, Lewis SA, Macfarlane JT. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377–82.CrossRef
26.
go back to reference Demedts M, Costabel U. ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Lausanne: European Respiratory Society; 2002.CrossRef Demedts M, Costabel U. ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Lausanne: European Respiratory Society; 2002.CrossRef
27.
go back to reference Floyd R. Organization of pneumonic exudates. Med Surg Rep. 1925;25:110. Floyd R. Organization of pneumonic exudates. Med Surg Rep. 1925;25:110.
28.
go back to reference Milne LS. Chronic pneumonia (including a discussion of two cases of syphilis of the lung). Am J Med Sci (1827–1924). 1911;142(3):408.CrossRef Milne LS. Chronic pneumonia (including a discussion of two cases of syphilis of the lung). Am J Med Sci (1827–1924). 1911;142(3):408.CrossRef
29.
go back to reference Rodríguez-Roisin R, Krowka MJ. Hepatopulmonary syndrome—a liver-induced lung vascular disorder. N Engl J Med. 2008;358(22):2378–87.CrossRef Rodríguez-Roisin R, Krowka MJ. Hepatopulmonary syndrome—a liver-induced lung vascular disorder. N Engl J Med. 2008;358(22):2378–87.CrossRef
30.
go back to reference Arslan S, Ugurlu S, Bulut G, Akkurt I. The association between plasma D-dimer levels and community-acquired pneumonia. Clinics (Sao Paulo). 2010;65(6):593–7.CrossRef Arslan S, Ugurlu S, Bulut G, Akkurt I. The association between plasma D-dimer levels and community-acquired pneumonia. Clinics (Sao Paulo). 2010;65(6):593–7.CrossRef
31.
go back to reference Almirall J, Bolíbar I, Toran P, Pera G, Boquet X, Balanzó X, Sauca G. Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia. Chest. 2004;125(4):1335–42.CrossRef Almirall J, Bolíbar I, Toran P, Pera G, Boquet X, Balanzó X, Sauca G. Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia. Chest. 2004;125(4):1335–42.CrossRef
32.
go back to reference Self WH, Balk RA, Grijalva CG, Williams DJ, Zhu Y, Anderson EJ, Waterer GW, Courtney DM, Bramley AM, Trabue C, et al. Procalcitonin as a marker of etiology in adults hospitalized with community-acquired pneumonia. Clin Infect Dis. 2017;65(2):183–90.CrossRef Self WH, Balk RA, Grijalva CG, Williams DJ, Zhu Y, Anderson EJ, Waterer GW, Courtney DM, Bramley AM, Trabue C, et al. Procalcitonin as a marker of etiology in adults hospitalized with community-acquired pneumonia. Clin Infect Dis. 2017;65(2):183–90.CrossRef
33.
go back to reference Chawla LS, Amdur RL, Faselis C, Li P, Kimmel PL, Palant CE. Impact of acute kidney injury in patients hospitalized with pneumonia. Crit Care Med. 2017;45(4):600–6.CrossRef Chawla LS, Amdur RL, Faselis C, Li P, Kimmel PL, Palant CE. Impact of acute kidney injury in patients hospitalized with pneumonia. Crit Care Med. 2017;45(4):600–6.CrossRef
34.
go back to reference Demirel B. Lactate levels and pneumonia severity index are good predictors of in-hospital mortality in pneumonia. Clin Respir J. 2018;12(3):991–5.CrossRef Demirel B. Lactate levels and pneumonia severity index are good predictors of in-hospital mortality in pneumonia. Clin Respir J. 2018;12(3):991–5.CrossRef
35.
go back to reference Poletti V, Cazzato S, Minicuci N, Zompatori M, Burzi M, Schiattone M. The diagnostic value of bronchoalveolar lavage and transbronchial lung biopsy in cryptogenic organizing pneumonia. Eur Respir J. 1996;9(12):2513–6.CrossRef Poletti V, Cazzato S, Minicuci N, Zompatori M, Burzi M, Schiattone M. The diagnostic value of bronchoalveolar lavage and transbronchial lung biopsy in cryptogenic organizing pneumonia. Eur Respir J. 1996;9(12):2513–6.CrossRef
36.
go back to reference Akira M, Yamamoto S, Sakatani M. Bronchiolitis obliterans organizing pneumonia manifesting as multiple large nodules or masses. AJR Am J Roentgenol. 1998;170(2):291–5.CrossRef Akira M, Yamamoto S, Sakatani M. Bronchiolitis obliterans organizing pneumonia manifesting as multiple large nodules or masses. AJR Am J Roentgenol. 1998;170(2):291–5.CrossRef
37.
go back to reference Wells AU. Cryptogenic organizing pneumonia. Semin Respir Crit Care Med. 2001;22(4):449–60.CrossRef Wells AU. Cryptogenic organizing pneumonia. Semin Respir Crit Care Med. 2001;22(4):449–60.CrossRef
Metadata
Title
Comparison of clinical features and prognosis in patients with cryptogenic and secondary organizing pneumonia
Authors
Keum-Ju Choi
Eun-Hyung Yoo
Kyung Chan Kim
Eun Jin Kim
Publication date
01-12-2021
Publisher
BioMed Central
Keyword
Pneumonia
Published in
BMC Pulmonary Medicine / Issue 1/2021
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-021-01707-z

Other articles of this Issue 1/2021

BMC Pulmonary Medicine 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.